NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Estimated value
—
goods
Awarded value
—
Suppliers
19
4 SME
Lots
6
16 awarded
Published
20 Jan 2025
Description
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin<br/><br/>Offer reference number: CM/PHS/23/5703<br/><br/>The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.
Scope
- Reference
- CM/PHS/23/5703
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2025 to 31 Dec 2027
- Main category
- goods
- CPV classifications
- 33651520
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 19 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
Lots · 6 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Lot 1 - Low and High Strength Albumin | £1 | cancelled |
| 2 | Lot 2 - 5% Intravenous Immunoglobulin | £1 | cancelled |
| 3 | Lot 3 - 10% Intravenous Immunoglobulin | £1 | cancelled |
| 4 | Lot 4 - Subcutaneous Immunoglobulin | — | cancelled |
| 5 | Lot 5 - Facilitated Subcutaneous Immunoglobulin | £1 | cancelled |